RecruitingNot Applicable

A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Overground Robotic Gait Treatments

Italy30 participantsStarted 2025-05-06

Plain-language summary

The study aims to identify neural biomarkers that can be used to monitor the recovery of locomotion and movement of post-stroke patients, both in natural settings and with enriched treatment using robotic device. These biomarkers could potentially be utilized in clinical practice to improve recovery outcomes. Additionally, the study seeks to investigate whether it is feasible to use these biomarkers to predict the extent of recovery that patients may achieve.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years old * Stroke patients with different etiology: ischemic or hemorrhagic * Able to walk independently, eventually with aids/orthosis (FAC\>2) * Able to give the informed consent and to comprehend the instructions necessary to complete the task * Subject's anthropometric parameters adequate to wear the exoskeleton; * Body weight \< 90 kg; * Height 150 ÷ 192 cm; * Thigh lenght: 355 ÷ 475 mm; * Calf lenght: 405 ÷ 485 mm; * Hip width : 690 ÷ 990 mm; Exclusion Criteria: * Incapacity to give the informed consent and understand the tasks required * Fixed contracture at lower limbs that limits the use of the exoskeleton * Incapacity to walk independently (FAC\<=2) * Subject's anthropometric parameters not adequate to wear the exoskeleton

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor outcome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Trial details

NCT IDNCT07510633

SponsorDr. Franco Molteni

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

Contact for this trial

Franco Molteni, MD

+39 031 8544219 fmolteni@valduce.it

View on ClinicalTrials.gov More Stroke trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor outcome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up